136 related articles for article (PubMed ID: 27515380)
21. Impact of Hypertriglyceridemia on Carotid Stenosis Progression under Normal Low-Density Lipoprotein Cholesterol Levels.
Kitagami M; Yasuda R; Toma N; Shiba M; Nampei M; Yamamoto Y; Nakatsuka Y; Sakaida H; Suzuki H
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1793-1800. PubMed ID: 28495179
[TBL] [Abstract][Full Text] [Related]
22. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
Nicholls SJ; Lincoff AM; Garcia M; Bash D; Ballantyne CM; Barter PJ; Davidson MH; Kastelein JJP; Koenig W; McGuire DK; Mozaffarian D; Ridker PM; Ray KK; Katona BG; Himmelmann A; Loss LE; Rensfeldt M; Lundström T; Agrawal R; Menon V; Wolski K; Nissen SE
JAMA; 2020 Dec; 324(22):2268-2280. PubMed ID: 33190147
[TBL] [Abstract][Full Text] [Related]
23. Elevated Serum Non-HDL (High-Density Lipoprotein) Cholesterol and Triglyceride Levels as Residual Risks for Myocardial Infarction Recurrence Under Statin Treatment.
Suzuki K; Oikawa T; Nochioka K; Miura M; Kasahara S; Sato M; Aoyanagi H; Shiroto T; Takahashi J; Miyata S; Sakata Y; Shimokawa H
Arterioscler Thromb Vasc Biol; 2019 May; 39(5):934-944. PubMed ID: 30866657
[TBL] [Abstract][Full Text] [Related]
24. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Sabatine MS; Giugliano RP; Keech AC; Honarpour N; Wiviott SD; Murphy SA; Kuder JF; Wang H; Liu T; Wasserman SM; Sever PS; Pedersen TR;
N Engl J Med; 2017 May; 376(18):1713-1722. PubMed ID: 28304224
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients.
Johannesen CDL; Mortensen MB; Langsted A; Nordestgaard BG
J Am Coll Cardiol; 2021 Mar; 77(11):1439-1450. PubMed ID: 33736827
[TBL] [Abstract][Full Text] [Related]
26. Target of Triglycerides as Residual Risk for Cardiovascular Events in Patients With Coronary Artery Disease - Post Hoc Analysis of the FMD-J Study A.
Kajikawa M; Maruhashi T; Kishimoto S; Matsui S; Hashimoto H; Takaeko Y; Yusoff FM; Kihara Y; Chayama K; Goto C; Noma K; Nakashima A; Tomiyama H; Takase B; Kohro T; Suzuki T; Ishizu T; Ueda S; Yamazaki T; Furumoto T; Kario K; Inoue T; Koba S; Watanabe K; Takemoto Y; Hano T; Sata M; Ishibashi Y; Node K; Maemura K; Ohya Y; Furukawa T; Ito H; Ikeda H; Yamashina A; Higashi Y
Circ J; 2019 Apr; 83(5):1064-1071. PubMed ID: 30918221
[TBL] [Abstract][Full Text] [Related]
27. Lipid Lowering Drugs: Present Status and Future Developments.
Ruscica M; Ferri N; Santos RD; Sirtori CR; Corsini A
Curr Atheroscler Rep; 2021 Mar; 23(5):17. PubMed ID: 33694108
[TBL] [Abstract][Full Text] [Related]
28. Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?
Fruchart JC; Hermans MP; Fruchart-Najib J; Kodama T
Curr Atheroscler Rep; 2021 Jan; 23(1):3. PubMed ID: 33392801
[TBL] [Abstract][Full Text] [Related]
29. Prognostic utility of triglyceride-rich lipoprotein-related markers in patients with coronary artery disease.
Cao YX; Zhang HW; Jin JL; Liu HH; Zhang Y; Xu RX; Gao Y; Guo YL; Zhu CG; Hua Q; Li YF; Santos RD; Wu NQ; Li JJ
J Lipid Res; 2020 Sep; 61(9):1254-1262. PubMed ID: 32641433
[TBL] [Abstract][Full Text] [Related]
30. Fasting and Non-Fasting Triglycerides and Risk of Cardiovascular Events in Diabetic Patients Under Statin Therapy.
Tada H; Nomura A; Yoshimura K; Itoh H; Komuro I; Yamagishi M; Takamura M; Kawashiri MA
Circ J; 2020 Feb; 84(3):509-515. PubMed ID: 32023582
[TBL] [Abstract][Full Text] [Related]
31. Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study.
Kim NH; Han KH; Choi J; Lee J; Kim SG
BMJ; 2019 Sep; 366():l5125. PubMed ID: 31562117
[TBL] [Abstract][Full Text] [Related]
32. Trajectories of Non-HDL Cholesterol Across Midlife: Implications for Cardiovascular Prevention.
Pencina KM; Thanassoulis G; Wilkins JT; Vasan RS; Navar AM; Peterson ED; Pencina MJ; Sniderman AD
J Am Coll Cardiol; 2019 Jul; 74(1):70-79. PubMed ID: 31272554
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of non-HDL cholesterol as a predictor of non-fatal cardiovascular events in a prospective population cohort.
Carbayo Herencia JA; Simarro Rueda M; Palazón Bru A; Molina Escribano F; Ponce García I; Artigao Ródenas LM; Caldevilla Bernardo D; Divisón Garrote JA; Gil Guillén VF;
Clin Investig Arterioscler; 2018; 30(2):64-71. PubMed ID: 29395492
[TBL] [Abstract][Full Text] [Related]
34. Remnant Cholesterol and Triglyceride-Rich Lipoproteins in Atherosclerosis Progression and Cardiovascular Disease.
Varbo A; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2133-2135. PubMed ID: 27784698
[No Abstract] [Full Text] [Related]
35. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
Castañer O; Pintó X; Subirana I; Amor AJ; Ros E; Hernáez Á; Martínez-González MÁ; Corella D; Salas-Salvadó J; Estruch R; Lapetra J; Gómez-Gracia E; Alonso-Gomez AM; Fiol M; Serra-Majem L; Corbella E; Benaiges D; Sorli JV; Ruiz-Canela M; Babió N; Sierra LT; Ortega E; Fitó M
J Am Coll Cardiol; 2020 Dec; 76(23):2712-2724. PubMed ID: 33272365
[TBL] [Abstract][Full Text] [Related]
36. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
Mach F; Baigent C; Catapano AL; Koskinas KC; Casula M; Badimon L; Chapman MJ; De Backer GG; Delgado V; Ference BA; Graham IM; Halliday A; Landmesser U; Mihaylova B; Pedersen TR; Riccardi G; Richter DJ; Sabatine MS; Taskinen MR; Tokgozoglu L; Wiklund O;
Eur Heart J; 2020 Jan; 41(1):111-188. PubMed ID: 31504418
[No Abstract] [Full Text] [Related]
37. Relationship between remnant cholesterol and short-term prognosis in acute ischemic stroke patients.
Tan Z; Zhang Q; Liu Q; Meng X; Wu W; Wang L; Wu J
Brain Behav; 2024 May; 14(5):e3537. PubMed ID: 38715443
[TBL] [Abstract][Full Text] [Related]
38. Glucagon-like Peptide-1 analogues and delipidation of coronary atheroma in statin-treated type 2 diabetic patients with coronary artery disease: The prespecified sub-analysis of the OPTIMAL randomized clinical trial.
Kataoka Y; Kitahara S; Funabashi S; Makino H; Matsubara M; Matsuo M; Omura-Ohata Y; Koezuka R; Tochiya M; Tamanaha T; Tomita T; Honda-Kohmo K; Noguchi M; Murai K; Sawada K; Iwai T; Matama H; Honda S; Fujino M; Nakao K; Yoneda S; Takagi K; Otsuka F; Asaumi Y; Hosoda K; Nicholls SJ; Yasuda S; Noguchi T
Atheroscler Plus; 2024 Jun; 56():1-6. PubMed ID: 38617596
[TBL] [Abstract][Full Text] [Related]
39. Gut permeability is associated with lower insulin sensitivity in youth with perinatally acquired HIV.
Dirajlal-Fargo S; Yu W; Jacobson DL; Mirza A; Geffner ME; Jao J; McComsey GA;
AIDS; 2024 Jul; 38(8):1163-1171. PubMed ID: 38564437
[TBL] [Abstract][Full Text] [Related]
40. The non-linear link between non-high-density lipoprotein to high-density lipoprotein ratio and the risk of stroke in middle-aged and older adults in Chinese: a prospective cohort study from the China health and retirement longitudinal study.
Wang L; Han Y; Cao C; Hu H; Li H
Front Endocrinol (Lausanne); 2023; 14():1303336. PubMed ID: 38288470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
